Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Harald J Hamre, Van N Pham, Christian Kern, Rolf Rau, Jörn Klasen, Ute Schendel, Lars Gerlach, Attyla Drabik & Ludger Simon. (2018) A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference. Patient Preference and Adherence 12, pages 375-397.
Read now
Read now
A Bilberg, T Bremell, J Bjersing & K Mannerkorpi. (2018) High prevalence of widespread pain in women with early rheumatoid arthritis. Scandinavian Journal of Rheumatology 47:6, pages 447-454.
Read now
Read now
AA Kiadaliri, L-E Kristensen & M Englund. (2018) Burden of rheumatoid arthritis in the Nordic region, 1990–2015: a comparative analysis using the Global Burden of Disease Study 2015. Scandinavian Journal of Rheumatology 47:2, pages 1-101.
Read now
Read now
T Uutela, H Kautiainen, S Järvenpää, S Salomaa, M Hakala & A Häkkinen. (2015) Patients with rheumatoid arthritis have better functional and working ability but poorer general health and higher comorbidity rates today than in the late 1990s. Scandinavian Journal of Rheumatology 44:3, pages 173-181.
Read now
Read now
J Jyrkkä, H Kautiainen, H Koponen, K Puolakka, LJ Virta, T Pohjolainen & E Lönnroos. (2014) Antidepressant use among persons with recent-onset rheumatoid arthritis: a nationwide register-based study in Finland. Scandinavian Journal of Rheumatology 43:5, pages 364-370.
Read now
Read now
KJ Aaltonen, T Sokka, T Möttönen, M Korpela, R Komulainen, T Uusitalo, S Salomaa, T Uutela, H Valleala & for the RAMI study group. (2014) A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland. Scandinavian Journal of Rheumatology 43:4, pages 286-290.
Read now
Read now
Articles from other publishers (12)
Paula Muilu, Vappu Rantalaiho, Hannu Kautiainen, Lauri J. Virta, Johan G. Eriksson & Kari Puolakka. (2020) First-year drug therapy of new-onset rheumatoid and undifferentiated arthritis: a nationwide register-based study. BMC Rheumatology 4:1.
Crossref
Crossref
Masanori Nakayama, Takefumi Furuya, Eisuke Inoue, Eiichi Tanaka, Katsunori Ikari, Atsuo Taniguchi, Hisahi Yamanaka & Masayoshi Harigai. (2020) Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study. Osteoporosis and Sarcopenia 6:2, pages 82-87.
Crossref
Crossref
Emeline Minichiello, Luca Semerano & Marie-Christophe Boissier. (2017) Incidence, prévalence et sévérité de la polyarthrite rhumatoïde au XXIe siècle. Revue du Rhumatisme Monographies 84:4, pages 303-310.
Crossref
Crossref
Émeline Minichiello, Luca Semerano & Marie-Christophe Boissier. (2017) Évolution dans le temps de la polyarthrite rhumatoïde : incidence, prévalence, gravité. Revue systématique de la littérature. Revue du Rhumatisme 84:1, pages 9-16.
Crossref
Crossref
Emeline Minichiello, Luca Semerano & Marie-Christophe Boissier. (2016) Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: A systematic literature review. Joint Bone Spine 83:6, pages 625-630.
Crossref
Crossref
P Elfving, K Puolakka, H Kautiainen, L J Virta, T Pohjolainen & O Kaipiainen-Seppänen. (2016) Drugs used in incident systemic lupus erythematosus – results from the Finnish nationwide register 2000–2007. Lupus 25:6, pages 666-670.
Crossref
Crossref
Annelie Bilberg, Tomas Bremell, Istvan Balogh & Kaisa Mannerkorpi. (2015) Significantly impaired shoulder function in the first years of rheumatoid arthritis: a controlled study. Arthritis Research & Therapy 17:1.
Crossref
Crossref
Vappu Rantalaiho, Hannu Kautiainen, Markku Korpela, Pekka Hannonen, Oili Kaipiainen-Seppänen, Timo Möttönen, Markku Kauppi, Anna Karjalainen, Kari Laiho, Leena Laasonen, Mikko Hakola, Ritva Peltomaa & Marjatta Leirisalo-Repo. (2014) Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial. Annals of the Rheumatic Diseases 73:11, pages 1954-1961.
Crossref
Crossref
K. Krüger. (2013) O’Dell reloadedO’Dell reloaded. Zeitschrift für Rheumatologie 73:2, pages 111-112.
Crossref
Crossref
Gabriela Schmajuk, Daniel H. Solomon & Jinoos Yazdany. (2013) Patterns of Disease-Modifying Antirheumatic Drug Use in Rheumatoid Arthritis Patients After 2002: A Systematic Review. Arthritis Care & Research 65:12, pages 1927-1935.
Crossref
Crossref
Ray Fitzpatrick, David GI Scott & Ian Keary. (2013) Cost-minimisation analysis of subcutaneous methotrexate versus biologic therapy for the treatment of patients with rheumatoid arthritis who have had an insufficient response or intolerance to oral methotrexate. Clinical Rheumatology 32:11, pages 1605-1612.
Crossref
Crossref
K. Krüger. (2011) Kombinationsbehandlung von Methotrexat mit DMARDs oder Biologika – Aktueller StandCombination therapy using methotrexate with DMARDs or biologics – current status. Zeitschrift für Rheumatologie 70:2, pages 114-122.
Crossref
Crossref